Atom | Development of novel small molecule antiviral therapeutics for pathogens with epidemic potential

Due Dates: April 13, 2027

Funding Amounts: €9–11 million per project; total call budget €44.2 million; 5 grants expected; project duration typically 3–5 years.

Summary: Funds research to develop new small molecule antivirals for epidemic-prone viruses, strengthening EU preparedness and innovation in antiviral therapeutics.

Key Information: Antibodies and antibody-derived proteins are excluded; only small molecule antivirals are eligible.

Development of novel small molecule antiviral therapeutics for pathogens with epidemic potential - European Commission

Sign in to see full grant listing